Innogenetics achieves CE mark for new human papillomavirus (HPV) genotyping test
Innogenetics announced that it has received CE marking for its new and expanded HPV genotyping test, the INNO-LiPA HPV Genotyping Extra. The new generation kit allows the genotyping of 28 different HPV genotypes, of which 18 are high-risk types for the possible development of cervical cancer. The test is based on Innogenetics' patent-protected SPF10 primers.
The INNO-LiPA HPV Genotyping Extra is designed for the identification of 28 different genotypes. The test encompasses 18 high-risk genotypes, including genotypes 16, and 18; 7 low-risk genotypes, including genotypes 6 and 11; and 3 additional genotypes. The useful information provided by the INNO-LiPA HPV Genotyping Extra can thereby serve as an important complement to Pap smear testing, and current DNA-based HPV screening tests. Automation is available, allowing the simultaneous processing of up to 48 different patient samples. Results are available within 3 hours.
Innogenetics will initially commercialize the product throughout Europe, where the product will be sold through its own specialized sales force. The INNO-LiPA HPV Genotyping Extra kit is anticipated to add to Innogenetics' revenues as of this quarter.
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.